公司概覽
業務類別 Biotechnology
業務概覽 Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. The company's pipeline products are the SB-001 and solid suit. The Company's singular focus is on developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.
公司地址 500 Rutherford Avenue, Third Floor, Charlestown, MA, USA, 02129
電話號碼 +1 617 337-4680
傳真號碼 --
公司網頁 https://www.solidbio.com
員工數量 100
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Dr. Paul Herzich, PhD Chief Technology Officer -- 25/04/2025
Dr. Jessie Hanrahan, PhD Chief Regulatory Officer -- 25/04/2025
Mr. David Tyronne Howton Chief Operating Officer and Secretary 美元 473.20K 25/04/2025
Mr. Kevin Tan Treasurer, Chief Financial Officer and Principal Accounting Officer -- 25/04/2025
Dr. Gabriel Brooks, M.D. Chief Medical Officer 美元 468.00K 25/04/2025
Mr. Alexander G. Cumbo President, Chief Executive Officer and Director 美元 608.40K 25/04/2025
 
董事會成員
董事會 職務 更新日期
Dr. Clare Kahn, PhD Independent Director 25/04/2025
Dr. Georgia Keresty, M.P.H.,PhD Independent Director 25/04/2025
Ms. Lynne Sullivan Independent Director 25/04/2025
Mr. Adam Stone Independent Director 25/04/2025
Mr. Ilan Ganot Director 25/04/2025
Dr. Martin Freed, F.A.C.P.,M.D. Independent Director 25/04/2025
Dr. Sukumar Nagendran, M.D. Independent Director 25/04/2025
Mr. Ian F. Smith Executive Chairman of the Board 25/04/2025
Mr. Alexander G. Cumbo President, Chief Executive Officer and Director 25/04/2025
 
所屬ETF (更新日期: 07/03/2026 03:39)
代號 名稱 佔比% 持有日期
IBBiShares Biotechnology ETF0.57%28/02/2026
VTWOVanguard Russell 2000 ETF0.36%31/01/2026
DFASDimensional US Small Cap ETF0.28%27/02/2026
IWCiShares Micro-Cap ETF0.20%28/02/2026
PRFZInvesco RAFI US 1500 Small-Mid ETF0.15%27/02/2026
AVSCAvantis US Small Cap Equity ETF0.12%28/02/2026
VTWVVanguard Russell 2000 Value ETF0.05%31/01/2026
DFAUDimensional US Core Equity Market ETF0.02%27/02/2026
DFACDimensional US Core Equity 2 ETF0.02%27/02/2026
DFSUDimensional US Sustainability Core 1 ETF0.01%27/02/2026
IBBQInvesco Nasdaq Biotechnology ETF0.01%27/02/2026
VTHRVanguard Russell 3000 ETF0.01%31/01/2026
IBRNiShares Neuroscience and Healthcare ETF0.005%28/02/2026
UWMProShares Ultra Russell20000.005%27/02/2026
URTYProShares UltraPro Russell20000.005%27/02/2026
BIBProShares Ultra Nasdaq Biotechnology0.005%27/02/2026
RFLRInnovator U.S. Small Cp Mgd Flr ETF0.003%25/02/2026
ITWOProShares Russell 2000 High Income ETF0.003%27/02/2026
MSSMMorgan Stanley Pathway Sm-Md Cp Eq ETF0.003%28/02/2026
DXUVDimensional US Vector Equity ETF0.003%27/02/2026
 1    2  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.